---
figid: PMC4994222__12974_2016_660_Fig6_HTML
figtitle: Summary diagram illustrates a hypothesis for how ZSTK474 exerts its effects
  on ischemic reperfusion injury
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Panax ginseng
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
pmcid: PMC4994222
filename: 12974_2016_660_Fig6_HTML.jpg
figlink: /pmc/articles/PMC4994222/figure/Fig6/
number: F6
caption: Summary diagram illustrates a hypothesis for how ZSTK474 exerts its effects
  on ischemic reperfusion injury. Administration of ZSTK474 after cerebral ischemic
  reperfusion injury decreases the number of microglia/macrophages and shifts their
  phenotype toward the more restorative state. This treatment reduces the level of
  pro-inflammatory cytokines and enhances the level of anti-inflammatory cytokines
  secreted. ZSTK474, a member of a specific class of IPI3K inhibitors, inhibits the
  phosphorylation of AKT to downregulate downstream mediators. The beneficial effects
  of ZSTK474 that we observed may result from inhibition of the mTORC1 pathway, which
  is an important downstream mediator of AKT-adjusted cell growth and translation
papertitle: Class I PI3K inhibitor ZSTK474 mediates a shift in microglial/macrophage
  phenotype and inhibits inflammatory response in mice with cerebral ischemia/reperfusion
  injury.
reftext: Po Wang, et al. J Neuroinflammation. 2016;13(1):192.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9447076
figid_alias: PMC4994222__F6
figtype: Figure
redirect_from: /figures/PMC4994222__F6
ndex: 8bf1b957-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4994222__12974_2016_660_Fig6_HTML.html
  '@type': Dataset
  description: Summary diagram illustrates a hypothesis for how ZSTK474 exerts its
    effects on ischemic reperfusion injury. Administration of ZSTK474 after cerebral
    ischemic reperfusion injury decreases the number of microglia/macrophages and
    shifts their phenotype toward the more restorative state. This treatment reduces
    the level of pro-inflammatory cytokines and enhances the level of anti-inflammatory
    cytokines secreted. ZSTK474, a member of a specific class of IPI3K inhibitors,
    inhibits the phosphorylation of AKT to downregulate downstream mediators. The
    beneficial effects of ZSTK474 that we observed may result from inhibition of the
    mTORC1 pathway, which is an important downstream mediator of AKT-adjusted cell
    growth and translation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pik3cg
  - Akt1
  - Tnf
  - Il18
  - Tgfb1
  - Il10
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - RPTOR
  - RPS6KB1
  - RPS6KB2
  - TNF
  - IL18
  - TGFB1
  - TGFB2
  - TGFB3
  - IL10
  - Pik3r1
  - Ecm1
  - Ppp1r13b
  - Pik3ca
  - Rps6kb1
  - Ltbp1
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Myb
  - Taf5
  - l(1)G0020
  - Taf4
  - Rpn2
  - Sap-r
  - Crtc
  - S6k
  - egr
  - dpp
  - gbb
  - put
  - mav
---
